← Back to Screener
Baird Medical Investment Holdings Ltd Ordinary Share (BDMD)
Price$1.26
Growth ScoreF
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-16.94%
Price vs S&P 500 (4W)-30.37%
VGM Score11.32
Market Capitalization$51.63M
P/E Ratio (Annual)5.76x
All Metrics
Book Value / Share (Quarterly)$1.02
P/TBV (Annual)1.55x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.05
Price vs S&P 500 (YTD)-11.02%
EPS (TTM)$-1.41
10-Day Avg Trading Volume0.13M
EPS Excl Extra (TTM)$-1.41
EPS (Annual)$-0.98
ROI (Annual)-53.99%
Gross Margin (Annual)83.79%
Cash / Share (Quarterly)$0.01
P/E Basic Excl Extra (TTM)61.85x
Revenue Growth QoQ (YoY)-39.15%
P/E Normalized (Annual)5.76x
ROA (Last FY)-39.14%
EBITD / Share (TTM)$-1.29
ROE (5Y Avg)-5.22%
Cash Flow / Share (Annual)$-0.05
P/B Ratio1.65x
P/B Ratio (Quarterly)1.55x
Net Income / Employee (Annual)$-186,800
Net Interest Coverage (TTM)-34.77x
ROA (TTM)-52.59%
EPS Incl Extra (Annual)$-0.98
Current Ratio (Annual)1.70x
Quick Ratio (Quarterly)1.34x
3-Month Avg Trading Volume1.51M
52-Week Price Return-70.24%
P/E Incl Extra (TTM)61.85x
Tangible BV / Share (Quarterly)$1.02
P/S Ratio (Annual)2.29x
Asset Turnover (Annual)0.32x
52-Week High$7.26
EPS Excl Extra (Annual)$-0.98
26-Week Price Return-5.56%
Quick Ratio (Annual)1.34x
13-Week Price Return-60.47%
Total Debt / Equity (Annual)0.61x
Current Ratio (Quarterly)1.70x
Enterprise Value$70.61M
Revenue / Employee (Annual)$154,400
Pretax Margin (Annual)-117.03%
Cash / Share (Annual)$0.01
3-Month Return Std Dev122.40%
Net Income / Employee (TTM)$-264,200
ROE (Last FY)-86.96%
Net Interest Coverage (Annual)-32.95x
EPS Basic Excl Extra (Annual)$-0.98
Total Debt / Equity (Quarterly)0.61x
EPS Incl Extra (TTM)$-1.41
ROI (TTM)-71.12%
Revenue / Share (Annual)$0.81
Tangible BV / Share (Annual)$1.02
Price vs S&P 500 (52W)-97.28%
P/E Ratio (TTM)61.85x
EPS Growth TTM (YoY)-75.06%
Year-to-Date Return0.00%
5-Day Price Return-8.72%
EPS Normalized (Annual)$-0.98
ROA (5Y Avg)-0.92%
Net Profit Margin (Annual)-121.04%
Month-to-Date Return-8.72%
EBITD / Share (Annual)$-0.88
Operating Margin (Annual)-113.73%
ROI (5Y Avg)-2.11%
P/E Excl Extra (TTM)61.85x
EPS Basic Excl Extra (TTM)$-1.41
P/TBV (Quarterly)1.55x
P/B Ratio (Annual)1.55x
Inventory Turnover (TTM)4.26x
Book Value / Share (Annual)$1.02
Price vs S&P 500 (13W)-70.97%
Beta-1.25x
ROE (TTM)-115.22%
52-Week Low$0.76
gGradeF
mGradeF
vgmGradeF
Show chart for
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BDMDBaird Medical Investment Holdings Ltd Ordinary Share | — | F | F | $1.26 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Baird Medical Investment Holdings Ltd is a Chinese provider of microwave ablation devices used to treat benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. The technology uses microwave energy to denature tumor cells through minimally invasive procedures, offering faster recovery times, lower complication rates, and easier operation compared to traditional surgical methods.